• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    January AI Raises $8.8 Million in New Funding

    FDA Clears Ava Fertility Tracking Wearable Device

    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System

    Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably

    Japan to Lead APAC Assisted Reproductive Technology Devices Market
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Rethink Your Medtech ASC Strategy, Part 1

    Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

    Tips for Reigniting Your MDR/IVDR Preparation

    Three Major Innovation Opportunities for Biomedical Textiles

    Use Vertical Integration to Increase Productivity, Drive Innovation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    maxon

    Creganna Medical, part of TE Connectivity

    FUTEK Advanced Sensor Technology Inc.

    Unicep

    PTI Engineered Plastics Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Refurbished Medical Equipment Testing and Certification Under the NEC

    Taking the First Step with Metal Components

    4 Trends Driving Medical Manufacturing in 2021

    Pioneering AI Solutions to Reinforce Healthcare Services

    The 8 Major Types of PPE Supply Chain Fraud
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Spectrum Plastics Group

    FUTEK Advanced Sensor Technology Inc.

    Medbio LLC

    maxon

    Unicep
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    The Economics of a Sound Regulatory Strategy

    While it might be tempting to put off regulatory requirements on a new project, a regulatory assessment should be performed fairly early.

    The Economics of a Sound Regulatory Strategy
    Christine Scifert and Dawn Norman, M.S., MRC-X LLC04.01.20
    The initial steps for medtech product development can be exciting and typically include designing initial concepts, branding logos, and tackling market assessments. Regulatory requirements, however, can quickly dampen the excitement. And while it might be tempting to put off these requirements, a regulatory assessment should be performed fairly early in a project. This assessment will provide direction related to device classification, submission pathway, testing strategies, and quality system mandates. Subsequently, a project plan can be developed to account for the resources, milestones, and activities that must be completed before commercialization.

    The regulatory assessment and project plan can provide clarity about cost and timing, as well as interactions between activities (i.e., parallel versus codependent actions). The sections review various topics a company should consider in preparing a project plan and market release schedule. This column addresses the FDA classifications and requirements involved in medtech product development; other regions outside the United States may have additional mandates.

    Startup companies must have an end goal in mind before embarking on their product development journey. These firms should decide if they want to operate independently as a medical device manufacturer, partner with a larger company, or sell their intellectual property. This decision will impact everything from quality system requirements to the necessary amount of testing and validation. The key question is “who will be the legal manufacturer of the medical device and what company name will be on the labeling?”

    The answer to that question will dictate whether a quality management system (QMS) should be implemented. Obviously, legal manufacturers without a QMS must implement one. But companies that provide product design and either partner with a legal manufacturer or sell their product rights do not need to implement a full quality system. Still, consideration should be given to implementing portions of the QMS related to design control, document control, supplier control, and risk management. Such documentation will likely make the product more appealing during the due diligence process.

    Clinical study requirements can be tricky to decipher. If the medical device under development is new and does not have a Class I exempt pathway or Class II pathway with a 510(k), clinical data will most likely be required. This will significantly increase time to market and product cost. An initial determination must be made about approving the study through the FDA’s Investigational Device Exemption (IDE) pathway or Investigational Review Board (IRB) channel (a non-significant risk trial). Regardless of the decision pathway, clinical studies can vary significantly depending on follow-up timing, requirements for radiographic images, blood testing, etc. All clinical studies used to support regulatory submissions must also be conducted under Good Clinical Practices to ensure proper site initiation, data monitoring, and final reporting. While short studies might be conducted for less than $1 million, it is difficult to match that cap for multi-year trials due to long-term follow-up requirements (implants, biologics, etc.), and the particular FDA regulatory pathway.

    Devices with user interfaces (patient monitors, infusion pumps, etc.) and/or those used at home without direct access to health facilities or medical practitioners are subject to recent standards such as IEC 62366 and FDA guidance documents related to usability (human factors) testing. These studies will not be as extensive as a clinical trial conducted for an IDE approval, but their overall design will be different than a clinical study. Thus, additional time and cost will be required. Additional consideration should be given to post-market studies, especially those pertaining to marketing claims and reimbursement.

    Besides clarifying a product’s clinical trial requirements, a regulatory assessment can help identify mechanical testing requirements based on existing FDA predicates (similar devices), product codes, and guidance documents. This testing must be performed on production-equivalent devices to ensure it is representative of what will eventually be distributed. Mechanical testing is typically outsourced and ranges from a few thousand dollars to $20,000-$30,000 per test. Animal studies (for safety or effectiveness purposes) hikes both costs and timelines. Animal studies typically take at least six months and can sometimes last one or two years depending on the follow-up time frame. These studies can cost anywhere from thousands to hundreds of thousands of dollars.

    Biocompatibility has always been important for FDA submissions, but the agency’s 2016 guidance document and subsequent updates to the ISO 10993:2018 standard have resulted in additional testing and biocompatibility risk assessments by independent microbiologists/toxicologists. These assessments are typically a few thousand dollars, but can easily approach $100,000 depending on the kind of testing required.

    Additional considerations for testing include electrical assays that should comply with IEC 60601 and relevant subparts. This kind of testing is extremely expensive, costing upwards of $60,000 or more, and must be conducted by a qualified test group.

    Validation is a key component of any regulatory submission. Companies submitting an application to the FDA or finalizing a design control file must complete applicable cleaning, sterilization, reliability, packaging, shipping, and shelf life validation. Decisions about sterilization methods (steam, gamma, EO) and the packaging configuration (individually packaged, non-sterile trays, kits) can significantly impact the timing and cost associated with these development activities and validations. These validations cost at least a few thousand dollars but can reach $50,000 or more.

    Any devices that have software or firmware components and/or transmit data must include software validations and also be assessed for cybersecurity. The time and cost associated with these validations are extremely variable and should be mapped out per project.

    Manufacturing is typically considered a post-market cost, but all products must be assessed for manufacturability and generate prototypes before commercial production begins. Once the overall manufacturing process steps are determined, validations must be conducted to ensure equipment, cleaning, set up, and inspections are in place prior to product distribution. Manufacturing times and costs are extremely variable and should be mapped out per project. Companies now must also consider the unique device identification and labeling requirements, validations, and accounts required to control barcodes/traceability.

    After collecting data, validating designs, performing other necessary validations, and initiating manufacturing, companies can circle back to the regulatory process. Only after all the information is available for a medical device can organizations submit their 510(k), De Novo, or Premarket Approval applications for FDA review. The company can prepare the submission itself or pay a consultant to prepare the submission. If a consultant is used, the cost varies significantly depending on the type of submission required, but the price tag is typically thousands of dollars. FY20 time frames and user fees associated with these submissions for standard and small business designation (SBD) are as follows:
    • 510(k): $11,594 ($2,800 for SBD)
      • Target FDA review time is 90 days but actual review time is typically four to five months
    • De Novo: $102,299 ($25,575 for SBD)
      • Target FDA review time is 150 days but actual review time varies. Companies should expect to wait at least eight months
    • PMA: $340,995 ($85,249 for SBD)
      • Note: Small businesses with approved SBD and gross receipts or sales of $30 million or less are eligible to have the fee waived on their first PMA
      • Target FDA review time is 180 days, but actual review time is typically 12-18 months. The review time can vary greatly depending on whether a panel is required and the timing to schedule an on-site audit

    Once a medical device’s classification is determined (Class I, Class II, or Class III) and the company is within 30 days of commercial distribution, an establishment registration user fee must be paid to FDA. This fee must be paid annually going forward, regardless of product sales. The FDA’s FY20 user fee is $5,236; there is no reduction in the establishment registration fee for small businesses.

    Conclusion
    Medtech firms should be careful in weighing the regulatory costs associated with getting devices to market. They should take into account considerations outlined in this column and prepare a project plan and schedule that makes allowances for all variables. These considerations pertain only to the U.S. market and FDA. Many of the testing mandates and validations will be applicable in other geographies, but every country has its own regulatory requirements, user fees and time frames to be considered. 


    Christine Scifert is co-founder of MRC-X LLC (previously Memphis Regulatory Consulting LLC), which offers medical device regulatory, quality and clinical services. She has been consulting for 10 years and has assisted both small and large medical device companies with strategy, regulatory submissions, quality systems, training, due diligence, and other activities. Prior to consulting, Scifert spent nine years at Medtronic Spinal and Biologics directing the regulatory department. Prior to Medtronic, she performed evaluations of injury mechanisms associated with automobile collisions, slip and falls, and sport/recreation accidents. Scifert earned a bachelor of science degree in physics from Hamline University and a master of science degree in biomedical engineering from the University of Iowa. She also completed a Master’s course in engineering management from Christian Brothers University.

    Before joining MRC-X in 2014, Dawn Norman spent 15 years in the medical device industry working with venture capital-backed startups and larger companies. She focused on regulatory strategy and submissions, along with clinical study design and study execution, for products such as magnetic navigation devices for neurosurgical, neurovascular, and cardiac indications; high intensity ultrasound for cardiac ablation; recombinant proteins for bone fusion; orthopedic trauma; and imaging technologies. Norman earned a bachelor of arts degree in biological sciences and chemistry, and a master of science degree in biomedical sciences from Southern Illinois University at Edwardsville.
    Related Searches
    • design
    • testing
    • health
    • medtech

    Related Columns

    • Surgical
      Rethink Your Medtech ASC Strategy, Part 1

      Rethink Your Medtech ASC Strategy, Part 1

      ASCs have adopted a strategy to focus on predictable, low-risk procedures with lower complication rates in an out-of-hospital setting.
      Maria Shepherd, President and Founder, Medi-Vantage 02.03.21

    • R&D & Design
      Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic restrictions may have diminished certain advantages large companies hold over small and mid-sized competitors.
      Dawn A. Lissy, President & Founder, Empirical 02.03.21

    • Tips for Reigniting Your MDR/IVDR Preparation

      Tips for Reigniting Your MDR/IVDR Preparation

      To get the MDR/IVDR preparation ball rolling again, here are four processes to help refocus on achieving compliance with the updated regulations.
      Nicolle Cannon, Founder and CEO, Cannon Quality Group LLC 02.03.21


    • Materials
      Three Major Innovation Opportunities for Biomedical Textiles

      Three Major Innovation Opportunities for Biomedical Textiles

      Biomedical textiles are gaining significant momentum for use in medical devices to facilitate less invasive surgical procedures.
      John Greco, Vice President of Sales, Cortland Biomedical 02.03.21

    • Contract Manufacturing
      Use Vertical Integration to Increase Productivity, Drive Innovation

      Use Vertical Integration to Increase Productivity, Drive Innovation

      The concept of vertical integration is simple: a company combining two or more stages of production that would normally be operated by separate companies.
      Ryan Lipe, Senior Vice President of Sales & Marketing, MGS 02.03.21

    • How to Better Prepare for Regulatory Requests and Minimize Impact

      How to Better Prepare for Regulatory Requests and Minimize Impact

      Pressure to increase efficiency in medical device development has been prevalent over the past year, especially with the intensified regulatory expectations.
      Sandi Schaible, Sherry Parker and Kim Ehman, WuXi AppTec Medical Device Testing 02.03.21


    • C-Suite Challenges in Medtech’s New Normal

      C-Suite Challenges in Medtech’s New Normal

      Many of the usual C-Suite management topics that are key to organizational success will remain the same this year.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 02.03.21

    • COVID-19: Accelerator of a Modern, Data-Driven Supplier Strategy

      COVID-19: Accelerator of a Modern, Data-Driven Supplier Strategy

      By the time COVID-19 arrived in the United States, global supply chains were already buckling under a historic level of demand.
      Denise Odenkirk, Vice President, Supplier Sales, Global Healthcare Exchange LLC 02.03.21

    • Fixing Face Mask Form and Function

      Fixing Face Mask Form and Function

      Masks for the general public are varied in both style and effectiveness.
      Sam Brusco, Associate Editor 11.04.20


    • Cardiovascular
      The Heart of the Matter: Trends in Cardiology

      The Heart of the Matter: Trends in Cardiology

      Of the three major segments of coronary stents, bioabsorbable stents are expected to have the highest growth between now and 2022.
      Maria Shepherd, President and Founder, Medi-Vantage 11.04.20

    • Virtually the Same? The Challenges of Online Conferences

      Virtually the Same? The Challenges of Online Conferences

      Like everyone else on the planet, I’m turning increasingly to virtual solutions to our physical challenges in the midst of a pandemic.
      Dawn A. Lissy, Founder & President, Empirical 11.04.20

    • Digital Health
      Digital Health Delivers During a Year for the Ages

      Digital Health Delivers During a Year for the Ages

      Internet of Medical Things technologies have emerged as the key enabler of a much more holistic and complete disease-state management toolbox.
      Brad Womble, Senior Director of Strategy, Marketing, and Mergers & Acquisitions, Jabil Healthcare 11.04.20


    • Advanced Technology for Staking and Swaging Medical Plastics

      Advanced Technology for Staking and Swaging Medical Plastics

      It reliably assembles heat- and vibration-sensitive components, and works with a wide range of plastic materials.
      Priyank Kishor, Global Product Manager—PulseStaking, Branson at Emerson 11.04.20

    • Quality Assurance When Supply Chain Disruptions Arise

      Quality Assurance When Supply Chain Disruptions Arise

      From supply chain disruptions to impromptu manufacturing modifications, the medical device industry has faced a whirlwind of complications in 2020.
      Sandi Schaible and Peter Steen, WuXi AppTec Medical Device Testing 11.04.20

    • The Top 30 and M&A in 2021: What’s Next?

      The Top 30 and M&A in 2021: What’s Next?

      With three of the top five companies appointing new CEOs in the last year and the global pandemic eroding earnings, M&A strategies could look a lot different.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 11.04.20


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • FDA Breakthrough Device Designation Given To MI Transcatheter Heart Pump
    • Refurbished Medical Equipment Testing And Certification Under The NEC
    Breaking News
    • January AI Raises $8.8 Million in New Funding
    • FDA Clears Ava Fertility Tracking Wearable Device
    • First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    • Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably
    • Japan to Lead APAC Assisted Reproductive Technology Devices Market
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • Seeking a Revolution in Clinical Care Through AI
    • Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit
    • Addition by Subtraction: The Latest of Machining for Medtech
    • Innovation Incubators: An R&D Roundtable
    • Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Preliminary Study Links Markers of Impaired Bone Health to Vegan Diet
    Refined Grains Linked to Heart Attack Risk, Early Death
    Kappa Bioscience Extends Research Partnership For COVID-19 Research
    Coatings World

    Latest Breaking News From Coatings World

    Nippon Paint Marine Wins Korea Export Award
    Universal Display Corporation, PPG Expand Global Production of UniversalPHOLED Materials
    PPG Introduces Premium Iso-free Primer Surfacer, Catalyst
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    January AI Raises $8.8 Million in New Funding
    FDA Clears Ava Fertility Tracking Wearable Device
    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Spark Therapeutics Appoints CTO
    Cryoport Launches ESG Program
    U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Top Beauty Products of 2021, According to HelloGiggles
    Estée Lauder Taps Ana de Armas as Global Brand Ambassador
    Sephora Announces Significant Expansion
    Happi

    Latest Breaking News From Happi

    What You're Reading on Happi.com
    Cosmetic Chemical Sales To Post CAGR 5.8% To 2025
    ACI Urges Senate to Approve Regan as EPA Administrator
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Marshall & Bruce Adds Koenig & Bauer Rapida 106 41-Inch Seven-Color Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    FTA converts Forum & INFOFLEX to virtual events
    Xeikon launches two new digital label printing presses
    UFlex adds capacity in packaging films
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Texas Medical Technology Partners with My Protect Kit
    Mexico City Single-Use Plastics Ban Leads to Tampon Shortage
    Believe Diapers Launch in U.S.
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    First Implantation of CTL Amedica's Minimally Invasive Flex Tower
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login